The latest price target for Steris (NYSE:STE) was reported by JMP Securities on April 10, 2025. The analyst firm set a price target for $265.00 expecting STE to rise to within 12 months (a ...

Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth ...

STERIS delivered solid Q3 results, driven by strong recurring revenue growth and margin improvements across healthcare and life sciences segments. However, healthcare capital equipment delays and ...